Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.00%
SPX
+0.52%
IXIC
+0.52%
FTSE
+0.72%
N225
+1.43%
AXJO
-0.43%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
-
Dividend Yield
0.00%
P/E Ratio
0.00
EPS
0.23
Revenue
18.95M
Avg. Volume
41.27K

About

What does RDHL do?
RedHill Biopharma develops medicines for gastrointestinal and infectious diseases, promoting drugs like Talicia for H. pylori infections and Aemcolo for travelers’ diarrhea. Their late-stage programs include RHB-204, opaganib, RHB-107, RHB-104, and RHB-102.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Israel
Website
http://www.redhillbio.com

Recently from Cashu

publisher logo
Cashu

Calibre One Appoints Jed Donnelly to Enhance Life Sciences Expertise for Redhill Biopharma.

2 days ago
publisher logo
Cashu

Calibre One Enhances Biopharmaceutical Search with Jed Donnelly; Impact on Redhill Biopharma?

4 days ago
publisher logo
Cashu

Redhill Biopharma's Commitment to Transparency Amid Legal Challenges in Biopharma Sector

15 days ago
Stocks
Health Care
rdhl
Redhill Biopharma
RDHL
0.00 (0.00%)
1.82
USD
At close at Jun 27, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials